Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Rheumatoid arthritis	3/93	0.00016720908178540931	0.0075244086803434185	37.99047619047619	-74.4091590745228	ATP6V0A2;ATP6V1A;TGFB1
KEGG_2021_Human	Collecting duct acid secretion	2/27	0.0004762361271499321	0.010715312860873471	80.43	-82.46855595798121	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Vibrio cholerae infection	2/50	0.0016370061401984127	0.02455509210297619	41.770833333333336	-50.1560330081587	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	2/70	0.0031848593502604382	0.03545473606099422	29.41176470588235	-37.553176952571945	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Synaptic vesicle cycle	2/78	0.003939415117888246	0.03545473606099422	26.289473684210527	-34.099339569929285	ATP6V0A2;ATP6V1A
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.042552456188519036	21.67391304347826	-28.742216935482162	DCN;TGFB1
KEGG_2021_Human	Oxidative phosphorylation	2/133	0.011103972768351109	0.07138268208225712	15.146946564885496	-20.537590301958808	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Phagosome	2/152	0.014335605230985022	0.08063777942429075	13.196666666666667	-17.909946150058477	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.09877513154031052	11.081460674157304	-14.950240051620256	ATP6V0A2;TGFB1
KEGG_2021_Human	Proteoglycans in cancer	2/205	0.025220492252545426	0.11349221513645442	9.685960591133005	-12.928804077098514	DCN;TGFB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.19479958822781665	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Human papillomavirus infection	2/331	0.06060431633754296	0.19479958822781665	5.880699088145897	-7.115618067766183	ATP6V0A2;ATP6V1A
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.19479958822781665	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	Arginine and proline metabolism	1/50	0.060233261208856796	0.19479958822781665	18.183673469387756	-10.63265628196324	PYCR1
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.20578635391744243	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	FoxO signaling pathway	1/131	0.1509099928727911	0.20578635391744243	6.7846153846153845	-3.968927686510734	TGFB1
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.20578635391744243	13.895833333333334	-8.322075559905016	TGFB1
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.20578635391744243	10.435294117647059	-6.300464747037211	TGFB1
KEGG_2021_Human	Chronic myeloid leukemia	1/76	0.09024597396088518	0.20578635391744243	11.841481481481482	-7.141387005986298	TGFB1
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.20578635391744243	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.20578635391744243	7.177055103884372	-4.231046804704064	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.20578635391744243	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.20578635391744243	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.20578635391744243	13.071895424836601	-7.854937277937848	TGFB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.20578635391744243	6.892361111111111	-4.041189892105298	TGFB1
KEGG_2021_Human	Lysosome	1/128	0.14769739689308778	0.20578635391744243	6.94750656167979	-4.078087345546839	ATP6V0A2
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.20578635391744243	7.00352733686067	-4.115510268264927	TGFB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.20578635391744243	11.841481481481482	-7.141387005986298	TGFB1
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.20578635391744243	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	Protein digestion and absorption	1/103	0.12049733874954198	0.20578635391744243	8.677559912854031	-5.2067399522157665	ELN
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.20578635391744243	8.345911949685535	-4.994589105830365	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.20578635391744243	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.20578635391744243	8.94388327721661	-5.375723879218761	TGFB1
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.21289138440571256	5.74800290486565	-3.2620286219941206	ATP6V1A
KEGG_2021_Human	Gastric cancer	1/149	0.16995776547310146	0.21289138440571256	5.945945945945946	-3.3986573195730956	TGFB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.21289138440571256	5.672401433691756	-3.209640069203435	TGFB1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.21289138440571256	5.422496570644719	-3.0356632226338247	TGFB1
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.21289138440571256	5.456866804692892	-3.0596637281364782	TGFB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.21289138440571256	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.21335145202450367	5.256819693945443	-2.919648521708157	TGFB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.24674942133760713	4.326732673267327	-2.2588473265567357	TGFB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.25760521071822834	4.001019367991845	-2.0240281738454993	TGFB1
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.3178721176044423	2.9484262419416005	-1.2588658824557653	TGFB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	1/295	0.310808292768788	0.3178721176044423	2.9380196523053668	-1.2513063817932166	TGFB1
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	TGFB1
